Reuters logo
9 months ago
BRIEF-Neovacs enrolls first US patient in phase IIb study of IFNa Kinoid for SLE treatment
November 7, 2016 / 6:17 AM / 9 months ago

BRIEF-Neovacs enrolls first US patient in phase IIb study of IFNa Kinoid for SLE treatment

Nov 7 (Reuters) - Neovacs SA :

* Neovacs enrolls the first US patient in phase IIb study of IFNa Kinoid for treatment of Systemic Lupus Erythematosus (SLE) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below